HK1072774A1 - Novel hydroxyalkyl indolocarbazole derivatives, p reparation method and pharmaceutical compositions containing same - Google Patents
Novel hydroxyalkyl indolocarbazole derivatives, p reparation method and pharmaceutical compositions containing sameInfo
- Publication number
- HK1072774A1 HK1072774A1 HK05102890A HK05102890A HK1072774A1 HK 1072774 A1 HK1072774 A1 HK 1072774A1 HK 05102890 A HK05102890 A HK 05102890A HK 05102890 A HK05102890 A HK 05102890A HK 1072774 A1 HK1072774 A1 HK 1072774A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing same
- indolocarbazole derivatives
- reparation method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0113576A FR2831169B1 (fr) | 2001-10-22 | 2001-10-22 | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2002/003592 WO2003035663A1 (fr) | 2001-10-22 | 2002-10-21 | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1072774A1 true HK1072774A1 (en) | 2005-09-09 |
Family
ID=8868539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05102890A HK1072774A1 (en) | 2001-10-22 | 2005-04-07 | Novel hydroxyalkyl indolocarbazole derivatives, p reparation method and pharmaceutical compositions containing same |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040242508A1 (es) |
EP (1) | EP1438320A1 (es) |
JP (1) | JP2005509641A (es) |
KR (1) | KR100588222B1 (es) |
CN (1) | CN1253463C (es) |
AR (1) | AR036898A1 (es) |
BR (1) | BR0213403A (es) |
CA (1) | CA2463923A1 (es) |
EA (1) | EA006201B1 (es) |
FR (1) | FR2831169B1 (es) |
HK (1) | HK1072774A1 (es) |
HU (1) | HUP0401885A2 (es) |
MX (1) | MXPA04003741A (es) |
NO (1) | NO20041761L (es) |
NZ (1) | NZ532365A (es) |
PL (1) | PL368237A1 (es) |
WO (1) | WO2003035663A1 (es) |
ZA (1) | ZA200402626B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1734963A4 (en) | 2004-04-02 | 2008-06-18 | Merck & Co Inc | METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER |
TWI499414B (zh) * | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法 |
WO2008109591A1 (en) * | 2007-03-08 | 2008-09-12 | Lexicon Pharmaceuticals, Inc. | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
CN104031052B (zh) * | 2014-05-20 | 2016-06-08 | 中国科学院南海海洋研究所 | 抗生素Indimicins A–E及其制备方法和在制备抗肿瘤药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000064917A2 (en) * | 1999-04-26 | 2000-11-02 | Advanced Life Sciences Inc. | Synthetic indolocarbazole regioisomers and uses thereof |
US6703373B1 (en) * | 1999-09-10 | 2004-03-09 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazole derivatives and antitumor agents |
FR2801054B1 (fr) * | 1999-11-17 | 2003-06-13 | Adir | Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2001
- 2001-10-22 FR FR0113576A patent/FR2831169B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-21 BR BR0213403-9A patent/BR0213403A/pt not_active IP Right Cessation
- 2002-10-21 CA CA002463923A patent/CA2463923A1/fr not_active Abandoned
- 2002-10-21 CN CNB02820784XA patent/CN1253463C/zh not_active Expired - Fee Related
- 2002-10-21 EA EA200400533A patent/EA006201B1/ru unknown
- 2002-10-21 EP EP02796813A patent/EP1438320A1/fr not_active Withdrawn
- 2002-10-21 NZ NZ532365A patent/NZ532365A/en unknown
- 2002-10-21 JP JP2003538176A patent/JP2005509641A/ja not_active Ceased
- 2002-10-21 KR KR1020047005995A patent/KR100588222B1/ko not_active IP Right Cessation
- 2002-10-21 PL PL02368237A patent/PL368237A1/xx not_active Application Discontinuation
- 2002-10-21 AR ARP020103953A patent/AR036898A1/es unknown
- 2002-10-21 WO PCT/FR2002/003592 patent/WO2003035663A1/fr not_active Application Discontinuation
- 2002-10-21 US US10/492,876 patent/US20040242508A1/en not_active Abandoned
- 2002-10-21 HU HU0401885A patent/HUP0401885A2/hu unknown
- 2002-10-21 MX MXPA04003741A patent/MXPA04003741A/es not_active Application Discontinuation
-
2004
- 2004-04-02 ZA ZA2004/02626A patent/ZA200402626B/en unknown
- 2004-04-29 NO NO20041761A patent/NO20041761L/no not_active Application Discontinuation
-
2005
- 2005-04-07 HK HK05102890A patent/HK1072774A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2003035663A1 (fr) | 2003-05-01 |
JP2005509641A (ja) | 2005-04-14 |
FR2831169B1 (fr) | 2003-12-12 |
KR20040054735A (ko) | 2004-06-25 |
CN1571793A (zh) | 2005-01-26 |
CN1253463C (zh) | 2006-04-26 |
FR2831169A1 (fr) | 2003-04-25 |
MXPA04003741A (es) | 2004-07-23 |
CA2463923A1 (fr) | 2003-05-01 |
PL368237A1 (en) | 2005-03-21 |
BR0213403A (pt) | 2004-11-03 |
US20040242508A1 (en) | 2004-12-02 |
EA006201B1 (ru) | 2005-10-27 |
NZ532365A (en) | 2005-07-29 |
NO20041761L (no) | 2004-04-29 |
HUP0401885A2 (hu) | 2004-12-28 |
ZA200402626B (en) | 2005-06-29 |
EP1438320A1 (fr) | 2004-07-21 |
KR100588222B1 (ko) | 2006-06-12 |
AR036898A1 (es) | 2004-10-13 |
EA200400533A1 (ru) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400989A3 (en) | Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
HUP0401718A3 (en) | Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them | |
HUP0402264A3 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof | |
HUP0400058A2 (hu) | Kondenzált heterogyűrűs vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0402161A3 (en) | Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0401900A3 (en) | 3-substituted-4-pyrimidone derivatives, pharmaceutical compositions containing them and their intermediates | |
AP2004003024A0 (en) | Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same. | |
HUP0402225A3 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
HUP0103063A3 (en) | Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
IL157740A0 (en) | Heterocyclic derivatives and pharmaceutical compositions containing the same | |
HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
HK1072774A1 (en) | Novel hydroxyalkyl indolocarbazole derivatives, p reparation method and pharmaceutical compositions containing same | |
PL352293A1 (en) | Derivatives of purine, method of making same and pharmaceutical compositions containing these derivatives | |
HK1071749A1 (en) | Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
PL356911A1 (en) | Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same | |
IL160984A0 (en) | Triazine derivatives and pharmaceutical compositions containing the same | |
PL366381A1 (en) | Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives | |
HUP0401018A3 (en) | 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
HUP0401082A3 (en) | Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them | |
HUP0400154A3 (en) | Heterocondesated benzoxazepine and benzoxathiazepine derivatives, their use and pharmaceutical compositions containing them | |
IL158660A0 (en) | Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same | |
PL360090A1 (en) | Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same | |
SI1245565T1 (en) | Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0402600A3 (en) | D-proline derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091021 |